Story perspectives

Breakthrough Triple-Drug Therapy Reprograms Cancer Cell Death

10/31/2025

26 3

Summary

Story summary

Researchers from the Institut Pasteur and Inserm developed a triple-drug therapy that reprograms cancer cell death and enhances the immune system's tumor-fighting ability.
The therapy targets malignant B cells, especially in blood cancers like lymphoma and leukemia.
It induces necroptosis and triggers immune responses, leading to leukemia elimination in preclinical models.
The findings were published in Science Advances with support from the European Research Council.

1 of 1

Story summary

Researchers from the Institut Pasteur and Inserm developed a triple-drug therapy that reprograms cancer cell death and enhances the immune system's tumor-fighting ability.
The therapy targets malignant B cells, especially in blood cancers like lymphoma and leukemia.
It induces necroptosis and triggers immune responses, leading to leukemia elimination in preclinical models.
The findings were published in Science Advances with support from the European Research Council.